By Linda Chiem ( April 29, 2014, 12:27 PM EDT) -- Bristol-Myers Squibb Co. has acquired iPierian Inc., a California biotechnology company that develops treatments for neurodegenerative diseases, for $175 million in cash upfront and potentially up to another $550 million in development and regulatory milestone payments, the companies said Tuesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.